Ceres Nanosciences Establishes Nine Wastewater-based COVID-19 Surveillance Centers of Excellence Under NIH RADx Initiative
PR92929
MANASSAS, Va., Nov. 10, 2021 /PRNewswire＝KYODO JBN/ --
Ceres Nanosciences (Ceres), a privately held company that makes innovative
products to improve life science research and diagnostic testing, is announcing
the establishment of nine wastewater-based epidemiology centers of excellence,
as part of the April 2021 (
) $8.2 million award from the National Institutes of Health (NIH) Rapid
Acceleration of Diagnostics (RADx(SM)) initiative.
Logo - https://mma.prnewswire.com/media/1492770/Ceres_Nanosciences_Logo.jpg
Wastewater-based epidemiology can help communities monitor infection dynamics
for SARS-CoV-2 and can serve as an early-warning system for the virus in a
population, but widespread implementation has been stymied by lack of robust,
high-throughput viral concentration methods.
Ceres' Nanotrap(R) Magnetic Virus Particles address this problem by enabling
rapid viral concentration directly from raw sewage, significantly reducing the
time and effort required to process samples. Wastewater testing methods powered
by Nanotrap(R) Particles enable wastewater-based epidemiology at multiple
levels in a community, including at the building level, at the neighborhood
sewershed level, and at the wastewater treatment plant level.
"Our customers have processed tens of thousands of samples from college dorms,
K-12 schools, sleepaway camps, government facilities, and wastewater treatment
plants," said Ben Lepene, Chief Technology Officer at Ceres Nanosciences. "A
recent study by one of our university customers showed that 85% of the
individual COVID-19 cases (
) on campus were preceded by positive wastewater results."
Each Center of Excellence was selected (
) based on its ability to utilize the expanded capacity to extend services into
underserved and underprivileged communities and to provide critical information
to public health decision makers. Each site received the materials and on-site
training from Ceres' field applications team to implement an automated
protocol, which increases capacity to 100 samples per day and improves
turnaround times to less than eight hours.
"These sites encompass non-profit, university, public health, and commercial
testing labs in eight states with a total population of more than 120 million
people," said Tara Jones-Roe, Vice President of Sales and Marketing for Ceres
Nanosciences. "We are very proud of this amazing set of organizations and look
forward to identifying additional sites."
The sites announced today are Arizona State University with OneWaterOneHealth,
CIAN Diagnostics, Public Health Laboratory of East Texas, University at
Buffalo, UCLA, UC Davis with UC Merced, University of Connecticut, University
of Kansas, and West Virginia University.
Full details are available at https://www.ceresnano.com/press-release-coe9
Press Contact:
Ross M. Dunlap
Ceres Nanosciences, Inc
1.800.615.0418 ext. 202
rdunlap@ceresnano.com
www.ceresnano.com
SOURCE Ceres Nanosciences, Inc
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
